We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35

Top Buys

Rank Stock Value
1
AVLN
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIT icon
51
Applied Industrial Technologies
AIT
$11.7B
$48.6M 0.65%
143,966
+22,679
+19% +$6.96M
MBX
52
MBX Biosciences
MBX
$3.06B
$48.2M 0.64%
873,492
-16,508
-2% -$577K
CYTK icon
53
Cytokinetics
CYTK
$10.1B
$48.1M 0.64%
564,398
+85,300
+18% +$6.12M
IONS icon
54
Ionis Pharmaceuticals
IONS
$10.1B
$45.6M 0.61%
575,000
– –
AVLN
55
Avalyn Pharma
AVLN
$1.54B
$45.3M 0.61%
+1,375,486
New +$39.7M
RVMD icon
56
Revolution Medicines
RVMD
$44.2B
$42.7M 0.57%
227,845
-33,580
-13% -$4.9M
STE icon
57
Steris
STE
$22.7B
$42.1M 0.56%
199,560
+4,925
+3% +$1.06M
BE icon
58
Bloom Energy
BE
$62.3B
$41.7M 0.56%
138,192
+432
+0.3% +$111K
FERG icon
59
Ferguson
FERG
$44.4B
$41.2M 0.55%
173,453
+3,993
+2% +$963K
IMMX icon
60
Immix Biopharma
IMMX
$990M
$40.1M 0.54%
3,891,019
+1,342,000
+53% +$12.4M
CDNS icon
61
Cadence Design Systems
CDNS
$93.6B
$39.1M 0.52%
104,219
+84,368
+425% +$29.6M
LOW icon
62
Lowe's Companies
LOW
$116B
$39M 0.52%
176,976
+6,341
+4% +$1.44M
AXON
63
Axon Enterprise
AXON
$49.1B
$38.9M 0.52%
69,514
-329
-0.5% -$138K
MDB icon
64
MongoDB
MDB
$35.6B
$38.6M 0.52%
114,962
+52,588
+84% +$15.8M
CLDX icon
65
Celldex Therapeutics
CLDX
$3.13B
$38.6M 0.52%
1,037,000
– –
FAST icon
66
Fastenal
FAST
$57.5B
$38.5M 0.52%
804,046
+6,461
+0.8% +$293K
FTDR icon
67
Frontdoor
FTDR
$5.65B
$37.7M 0.5%
486,594
+362
+0.1% +$23.2K
TLN
68
Talen Energy Corp
TLN
$14.3B
$37.5M 0.5%
97,373
-19,810
-17% -$7.26M
KMTS
69
Kestra Medical Technologies
KMTS
$1.52B
$36.8M 0.49%
1,446,742
+878
+0.1% +$18.4K
TMDX icon
70
Transmedics
TMDX
$3.11B
$36.5M 0.49%
548,874
+50
+0% +$4.23K
PVLA
71
Palvella Therapeutics
PVLA
$2.17B
$35.4M 0.47%
231,484
-1,764
-0.8% -$214K
APGE icon
72
Apogee Therapeutics
APGE
$10.2B
$34.5M 0.46%
260,000
-297,423
-53% -$26.8M
FIX icon
73
Comfort Systems
FIX
$54.2B
$34.4M 0.46%
17,370
+8,563
+97% +$15.5M
DXCM icon
74
DexCom
DXCM
$34.2B
$33.6M 0.45%
498,202
+3,199
+0.6% +$213K
DFTX
75
Definium Therapeutics
DFTX
$5.57B
$33.4M 0.45%
710,000
+23,838
+3% +$589K
1 2
3
4 5

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.